The patent, entitled "Detection of a biomarker in a sample of a flowable substance" and application number 16/477143, covers the entire POC system and the method of detecting a biomarker in eg blood. The patent provides protection until 2038. The Notice of Allowance means that the USPTO will approve the company's patent application.
Including the new patent, Calmark owns seventeen patents and design protection for both the instrument and the test cassette on important markets.
"Today's news is gratifying," says Anna Söderlund, CEO of Calmark. “For Calmark, it is strategically important to have broad patent protection for the company's technologies and methods, it protects us from competition and plagiarism. We work continuously to file patents for our innovations.”
Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.